Safety and Tolerability, and PK of Sibeprenlimab in Chinese Healthy Subject

Clinical trial NCT07105124 · COMPLETED

Trial details

NCT number: NCT07105124
Sponsor: Otsuka Beijing Research Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects (HS)

Start date: 2022-10-18
Primary completion: 2023-02-15
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.